Skip to content

Benjamin Guérin

6 papers in the library · 94 citations · publishing 2021-2025

Papers

Sort Most recent Most cited

Les facultés thérapeutiques des psychédéliques

Etudes December 30, 2025 Benjamin Guérin

Les psychothérapies assistées par psychédéliques (PAP), en anglais Psychedelic-Assisted Therapies (PAT), sont des thérapies qui supposent le recours à des substances psychotropes, telles que la psilocybine ou le LSD. En plein essor, ces psychothérapies assistées par psychédéliques semblent efficaces dans les cas de troubles dépressifs sévères ou de détresse existentielle. S’appuyant sur un...

“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy

Psychedelic Medicine October 8, 2025 Elise C. Tarbi, Skye A. Miner, Kabir Nigam et al. 1 citation

Background: Cancer poses an existential threat for patients and caregivers. Psilocybin-assisted therapy (PAT) has emerged as a potential tool to meet these existential needs, yet little is known about how patients describe this element of their cancer journey, and how it might be affected by PAT, especially in the group therapy context. Purpose: To explore how patients with cancer and...

DOI: 10.1177/28314425251370303 (opens in new tab) Psilocybin Existentialism Cancer Perspective graphical +6

Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

General Hospital Psychiatry 2025 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam et al. 3 citations

Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited. This study explores factors influencing the acceptability of PAT...

Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis

Cancer December 18, 2023 Yvan Beaussant, Kabir Nigam, Zachary Sager et al. 22 citations

Abstract Background The present study explored the acceptability of psilocybin‐assisted group therapy from the perspective of patients with cancer and depression who participated in a clinical trial assessing the safety and efficacy of this novel intervention. Methods Guided by the conceptual framework of acceptability, the authors conducted semi‐structured interviews with participants of the...

DOI: 10.1002/cncr.35024 (opens in new tab) Psilocybin Psychotherapist Clinical psychology Thematic analysis +2

Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Journal of Palliative Medicine April 13, 2021 Yvan Beaussant, James A. Tulsky, Benjamin Guérin et al. 34 citations

Background: With support from the Radcliffe Institute for Advanced Study at Harvard University, we convened researchers representing palliative care, psychosocial oncology, spiritual care, oncology, and psychedelic-assisted therapies. We aimed to define priorities and envision an agenda for future research on psychedelic-assisted therapies in patients with serious illness. Over two days in...

DOI: 10.1089/jpm.2020.0764 (opens in new tab) Full text (opens in new tab) Psychedelic medicine Hallucinogen therapy Mental health: well-being Psychological health +8

Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Journal of Palliative Medicine April 13, 2021 Yvan Beaussant, James A. Tulsky, Benjamin Guérin et al. 34 citations

Background: With support from the Radcliffe Institute for Advanced Study at Harvard University, we convened researchers representing palliative care, psychosocial oncology, spiritual care, oncology, and psychedelic-assisted therapies. We aimed to define priorities and envision an agenda for future research on psychedelic-assisted therapies in patients with serious illness. Over two days in...

DOI: 10.1089/jpm.2020.0764 (opens in new tab) Full text (opens in new tab) Psychedelic medicine Hallucinogen therapy Mental health: well-being Psychological health +8